Intro to Drug Metabolism & Phase I Metabolism Flashcards

(98 cards)

1
Q

Why are some drugs/xenobiotics metabolized?

A

It’s a defense mechanism
- To increase water solubility of hydrophobic molecules for excretion
- To protect against all types of “reactive” molecules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Where are drugs/xenobiotics metabolized?

A

In the liver
- gets absorbed in the gut and does the first-pass right after which has an impact on oral F (decreases the fraction that gets through)
- Every subsequent pass – CLH (metabolism of a portion of drug molecules in systemic circulation occurs on every pass back through the liver)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How are drugs/xenobiotics metabolized?

A

Phase I enzymes & Phase II enzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Two general sets of enzyme-catalyzed reactions

A

– Phase I enzymes: introduce or expose polar groups
– Phase II enzymes: “synthetic” – form conjugates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What affects the rates of drug/xenobiotic metabolism?

A
  1. Enzyme expression levels (when enzyme expression increases, the rate of clearance will increase because you have more enzyme that catalyzes the reaction)
  2. Inhibition (if you bind something to the enzyme and inhibit it, clearance decreases)
  3. Genetic polymorphisms/variability
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

The balanced molecular properties that drugs need:

A
  • aqueous solubility high enough to dissolve in the
    gut to drive absorption and to reach concentrations high enough to saturate receptor in tissues
  • hydrophobic enough to diffuse across membranes
    and, in many cases, to enhance binding affinity to receptor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

A drug is excreted unchanged via

A

kidney

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What does it mean when a drug is metabolized?

A

chemical structures and properties are changed through enzyme-catalyzed reactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

These drugs may be excreted primarily
unchanged:

A

Polar and ionic drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Hydrophobic drugs are metabolized to become

A

polar, ionic and more water soluble

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Orally delivered drugs are subject to both

A

prehepatic metabolism in the gut and more
extensive first-pass metabolism in the liver that
lowers bioavailability.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Two types of Enzyme-Catalyzed Reactions

A
  1. Primarily Xenobiotic
  2. Primarily Endobiotic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Primarily Xenobiotic

A

not expected to be in body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Primarily Endobiotic

A

synthesized in body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Phase I Class of Drug Metabolizing Enzymes

A

Introduce or Expose Polar Groups

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Phase II Class of Drug Metabolizing Enzymes

A

Use “activated cofactors” to form drug-conjugates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Phase I Groups

A

Oxidation
Oxidation/Reduction
Hydrolysis/Hydration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Phase II Groups

A

Nucleophile in Drug
Electrophile in Drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Oxidation

A
  1. Cytochrome P450 (CYP)
  2. Flavin Monooxygenase (FMO)
    - Require NADPH + O2
    - reveal a nucleophile: a Phase I Rxn
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Oxidation/Reduction

A
  1. Alcohol Dehydrogenase (ADH)/Carbonyl Reductase (CBR)
  2. Aldehyde Dehydrogenase (ALDH)
    - Require NAD+/NADH
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Hydrolysis/Hydration

A
  1. Esterase (CES)
  2. Amidase
  3. Epoxide Hydrolase (EH)
    - Reactions with H2O
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Nucleophile in Drug

A

Glucuronosyl Transferase (UGT)
Sulfotransferase (SULT)
N-Acetyl Transferase (NAT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Electrophile in Drug

A

Glutathione S-Transferase (GST)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

CYPs

A
  • aliphatic C-H -> C-OH
  • N-, O-, S-dealkylation
  • dehalogenation
  • aromatic C-H -> C-OH
  • epoxidation C=C
  • N-H -> N-OH
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
CYPs & FMOs
N-, S-oxidation
26
ADH & ALDH
- R2CHOH --> R2C=O - aldehyde oxidation RCH=O -> RCO2H
27
Esterase Amidase
- ester hydrolysis - amide hydrolysis
28
Epoxide hydrolase
epoxide hydration
29
- glucuronides – UGTs - sulfates – SULTs - peptide conjugates – N-acyl-amino acid transferases
Form conjugates to increase water solubility
30
- N-acetylation – NATs - methylation – methyl transferases
Form conjugates to decrease nucleophilic reactivity
31
glutathione conjugates – GSTs
Form conjugates to eliminate reactivity and increase water solubility
32
Each drug may be metabolized via
one or more single or multi-step pathways
33
Which enzyme(s) are responsible for ”clearance” of a given drug depends on
the chemical structure of the drug
34
Common Path of Metabolism for Hydrophobic Drugs
35
nucleophile
- a chemical species or an atom within a molecule that has a tendency to donate a pair of electrons to another atom - their electron-rich nature allows them to seek out and react with electron-deficient species - Examples include negatively charged ions like hydroxide ions (OH-), chloride ions (Cl-), and cyanide ions (CN-)
36
Phase I reactions increase
water solubility to some extent
37
Phase II anionic conjugates dramatically increase
water solubility and lead to excretion
38
Predominant pathways for first metabolites depend on
key structural features
39
Phase I oxidations (CYP reactions) dominate in
the absence of polar nucleophiles
40
Phase II conjugations (UGT) dominate if
polar nucleophile present
41
Various outcomes from these biotransformations
- active drug --> active metabolite - active drug --> inactive metabolite - active drug --> reactive "metabolite" - inactive (prodrug) --> active metabolite (“drug”)
42
Pharmacologically inactive prodrugs become activated by
one of the drug metabolizing enzymes
43
The most common prodrug design utilizes
esters that are hydrolyzed to active acids or alcohols
44
Genetic polymorphisms/variability
presence of different versions of a gene or DNA sequence within a population, resulting in genetic diversity among individuals. - may lower kcat --> lower rate - may increase km --> lower rate - may have opposite effect on km or kcat --> higher rate - may have gene copies --> more total energy, higher rate
45
Rates are directly proportional to
Enzyme expression levels
46
Rates can be affected by
inhibitors of the drug-metabolizing enzymes
47
Rates in different individuals may vary because of
genetic polymorphisms
48
Polar and ionic drugs may be excreted primarily
unchanged
49
Hydrophobic drugs are more extensively
metabolized
50
Phase I reactions primarily introduce or “expose” nucleophiles that are then subject to
Phase II conjugation reactions
51
Phase II reactions form conjugates of drug nucleophiles or electrophiles with groups that
- eliminate that reactivity - increase the size of the conjugate - introduce a low pKa anionic group that significantly increases water solubility
52
Enzymes catalyzing major initial transformations of parent drugs in the liver are key to
- clearance of drug - potential drug-drug interactions - variability in patient response
53
Orally delivered drugs are subject to both
- prehepatic metabolism in the gut - more extensive first-pass metabolism in the liver
54
Biotransformations may convert
- active drugs into inactive metabolites - active metabolites - reactive metabolites that can lead to various types of toxicities
55
Absorption
Hydrophilic enough to dissolve in the gut
56
Distribution
Hydrophobic enough to diffuse across cell membranes
57
Metabolism
- increase water solubility of hydrophobic drugs to be excreted - Protect against reactive molecules - where: Liver (majority), gut, lungs - how: first-pass metabolism, Phase I and Phase II reactions
58
Excretion
urine and/or feces - Polar/ionic drugs mainly excreted unchanged by the kidney - Metabolized drugs become more water soluble for entry into tubule lumen ⇨ urine
59
First-Pass Metabolism
Fraction of orally delivered drugs are subject to both pre-hepatic metabolism in the gut and more extensive first-pass metabolism in the liver which decreases bioavailability (F) before reaching systemic circulation
60
If you want to increase the bioavailability (F) of a drug substantially, what can you do?
Give the drug IV
61
What leads to the pk differences in IV vs oral administration?
IV avoids first-pass CYP enzymes in gut/liver, 100% enters systemic circulation
62
The fraction of oral drug that is absorbed and escapes both gut and liver first-pass metabolism ultimately becomes the fraction that
is fully available for your body to use, aka F < 1.
63
Some drugs are administered as Prodrugs that become activated by
first-pass metabolism
64
Enzyme catalyzed reactions that introduce or expose
polar groups
65
Oxidation
- Require NADPH + O2 - CYPs and FMOs
66
Oxidation/Reduction
- Require NAD+/NADH - ADH/CBR, ALDH
67
Hydrolysis
- Reactions with H2O - Esterase, Amidase, Epoxide Hydrolase
68
Phase I Metabolism
- Increase water solubility to some extent - Dominate in absence of polar nucleophiles
69
Phase II Metabolism
- Increase water solubility dramatically and lead to excretion (urine/feces) - Dominate if polar nucleophile is present
70
In Phase II Metabolism, enzyme catalyzed reactions use
activated cofactors to form drug conjugates
71
Nucleophile in drug
- Form conjugates to increase water solubility (UGTs, SULTs, N-acyl-amino acid transferases) - Form conjugates to decrease nucleophilic activity (NATs, methyl transferases)
72
Electrophile in drug
For conjugates to eliminate reactivity and increase water solubility (GSTs)
73
Prodrugs and Possible Pathways
- active drug --> active metabolite - active drug --> inactive metabolite - active drug --> reactive metabolite
74
What are some factors that can affect the rate of a reaction and efficacy of the drug?
- enzyme levels - enzyme inhibitors (DDIs) - genetic polymorphisms - enzyme saturation
75
Reactions that come from CYP enzymes
1. Aliphatic hydroxylation 2. N-H Hydroxylation 3. Epoxidation 4. Aromatic Hydroxylation 5. N-Oxidation 6. O-dealkylation 7. N-dealkylation 8. Dehalogenation
76
N-dealkylation
77
N-Oxidation
- O is added
78
Dehalogenation
79
N-H Hydroxylation
- you add an alcohol group
80
Aliphatic hydroxylation
hydroxyl group
81
O-dealkylation
methyl group is being removed
82
Aromatic
83
Epoxidation
84
What are the major CYP families that are involved in ~90% of drug/xenobiotic metabolism?
- CYP 1A - CYP 2C/D/E - CYP 3A
85
Which subfamilies have the highest 3 proportions of drug metabolism?
- CYP 3A4/5 - 2D6 - 2C9
86
Amidases
87
Esterases
88
ADH- alcohol dehydrogenase
89
ALDH - aldehyde dehydrogenase
90
EH - epoxide hydrolase
91
Carbonyl reductase
92
ADH/CBR are
REVERSIBLE redox reactions of alcohols to aldehydes/ketones (and vice versa)
93
Why do we need to remove aldehydes?
Aldehydes can react to amines on proteins and modify their function
94
Which drug do we use to treat alcohol abuse?
Disulfiram. By inhibiting ALDH we increase the buildup of aldehyde leading to bad SE.
95
Does 1st pass metabolism affect a drug’s clearance?
No! First pass metabolism affects the bioavailability (F) of the drug prior to it reaching systemic circulation. Since clearance is defined by the removal of parent drug from the body once it has been in systemic circulation, first pass metabolism would not be included
96
Phase I Reactions expose/introduce polar groups, revealing nucleophiles making the drug MORE
water soluble, and can lead to EASIER excretion.
97
If a drug is ANIONIC it will most likely need
TRANSPORTERS (and is usually highly water soluble!) - Phase I rxns increase water solubility LESS than Phase II rxns
98
From a Phase I reactions, drugs can either
be completely eliminated or further metabolized by Phase II enzymes/rxns